STOCKSCREENR
Log In

VTAK

AMEX

Catheter Precision, Inc.

$1.31-0.10(-7.09%)Mkt Cap: $1.61M

Key Stats

Market Cap

$1.61M

P/E Ratio

0.04

EPS

$36.33

Dividend Yield

0.00%

52-Week Range

$1.14 — $15.77

Volume

245.17K

Avg Volume

1.14M

Beta

-0.16

Valuation

P/E (TTM)

0.04

Forward P/E

—

PEG Ratio

-0.13

P/S (TTM)

2.20

P/B (TTM)

2.55

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-2.09%

ROA (TTM)

-0.68%

ROIC

—

Gross Margin

0.20%

Operating Margin

-19.63%

Net Margin

—

Debt/Equity

0.51

Current Ratio

0.46

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.63%

EPS Growth (5Y)

+0.69%

Sales Growth (3Y)

+10.05%

Sales Growth (5Y)

+5.66%

EPS Est (This Year)

$-60.80

EPS Est (Next Year)

—

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.08

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

0

Outstanding Shares

1.23M

Float

1.21M

Free Float %

98.47%

About

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

AMEX

IPO Date

2018-09-27

Employees

22

CEO

David A. Jenkins

Index Membership

—

Website

https://www.catheterprecision.com

Catheter Precision, Inc. (VTAK) is a healthcare company in the medical - devices industry listed on the AMEX. With a market capitalization of $1.61M, a P/E ratio of 0.04, VTAK is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare VTAK against other stocks using dozens of fundamental and technical filters.

Similar Stocks

NXL

Nexalin Technology, Inc.

$0.41

+0.57%

$7.63M

HSCS

HeartSciences Inc.

$2.65

-0.37%

$5.95M

BBLG

Bone Biologics Corporation

$1.24

+1.64%

$2.23M

NAOV

NanoVibronix, Inc.

$1.90

+1.06%

$1.51M

VVOS

Vivos Therapeutics, Inc.

$1.32

+1.54%

$7.77M

PAVM

PAVmed Inc.

$10.39

+3.38%

$5.58M

Frequently Asked Questions

What is Catheter Precision, Inc.'s P/E ratio?

Catheter Precision, Inc. (VTAK) has a trailing twelve-month (TTM) P/E ratio of 0.04. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Catheter Precision, Inc. pay a dividend?

No, Catheter Precision, Inc. (VTAK) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Catheter Precision, Inc.'s market cap?

Catheter Precision, Inc. (VTAK) has a market capitalization of $1.61 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.